semaglutide death The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Mom Dies After Using Weight

CGM (N=101) + GLP-1 vs GLP-1 only (N=5840)

Medicare Part D coverage expansion: The proposed CMS rule allowing Medicare Part D plans to cover anti-obesity medications would make 31 million Medicare beneficiaries with obesity eligible for semaglutide and tirzepatide, representing a USD 55.8 billion annual drug spend potential at 15% initial penetration

Then, the GST moiety was removed by PreScission protease (C610303, Sangon) and chorismite mutase activity assays were performed

NAD+ therapy Eden offers NAD+ (nicotinamide adenine dinucleotide) in multiple delivery formats including injections, creams, and nasal spray